Cargando…
Can Clinicians Start Prescribing Inclisiran for Hypercholesterolemia Today? A Review of Clinical Studies for Internal Medicine Physicians and Endocrinologists
The safety profile and efficacy margin of inclisiran as a lipid-lowering drug have been assessed in clinical trials and are underway in subgroups with relevant co-morbidities. This systematic review looks at the clinical trials that have been conducted to comment on its safety and efficacy. The conc...
Autores principales: | Jahangir, Abdullah, Sahra, Syeda, Krzyzak, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388613/ https://www.ncbi.nlm.nih.gov/pubmed/34462692 http://dx.doi.org/10.7759/cureus.16664 |
Ejemplares similares
-
Normal Saline Versus Low Chloride Solutions in Treatment of Diabetic Ketoacidosis: A Systematic Review of Clinical Trials
por: Jahangir, Ahmad, et al.
Publicado: (2022) -
Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic
por: Murayama, Anju, et al.
Publicado: (2022) -
The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin Dilemma
por: Hussain, Azhar, et al.
Publicado: (2023) -
ODP193 Endocrinologists’ Experiences with Telehealth: Organizational and Logistical Issues with Implementation
por: Wong, Denise, et al.
Publicado: (2022) -
ODP637 Clinical Appropriateness of Telehealth: A Qualitative Study of Endocrinologists’ Perspectives
por: Bolton, Rendelle, et al.
Publicado: (2022)